跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irbedrosaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irbedrosaph
Approved
STANDARD
Irbedrosaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f477be425b8265e7
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
f477be425b8265e7
Drug Approval Philippines Name
Irbedrosaph
Product Name
Irbedrosaph
Registration Number
DRP-12897
Brand Name
Irbedrosaph
Generic Name
Irbesaph + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
150mg/12.5 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Ollen Pharma Trading, Inc.
Distributor
Ollen Pharma Trading, Inc.
Issuance Date
26 October 2022
Expiry Date
26 October 2027
Pharmacologic Category
Angiotensin-II Receptor Blocker (ARB)/Diuretic (Thiazide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f477be425b8265e7
Type
Standard
Back to Philippines FDA Approvals